Member Info for Uncanny

I would say volumes are going to start creaping up as we move in to the 4th qtr ahead of value enhancing news as we are led to believe. If as John says PSA is c. 50% on 201 and we get a lucrative 401 deal soon, then that will light the blue touch paper on the VAL rocket! Just hold the price steady please until mid October when my Next free monies arrive and keep pisting negative and deramping guys.

Happy for it to stay here during Oct to get to my target holding!

There was more on offer today than selling so I tend to think buyers are covering the placed shares, but happy to take another 300k in the last week. Not sure about the timing but the chart are coming to a crescendo whether a bullish triangle formation, a positive bowl formation or Gartley pattern which is well followed! Technically we should have blast off in Oct but we need the catalyst - 401 JV / reg sign off? Its coming IMHO either TA or fundamentally. GLA

I guess VAL cannot mention an in-principal 401 deal until regs are done first. They’d look a bit stupid to announce a deal and then find out there’s hold up with the regs for whatever reason. Patience guys.

“then threaten to go broke again. Like they did last time.” Please provide a link to these claims.

The question to ask is what is a fait price for 401..... what would the market pay for the compound for a commwecial interest, in addition to funding CTlll. A potential life prolonging cancer compound should be worth a nice sum if the science stacks up which we are told it does from results of CT l, l/ll and ll.

All depends on what they get for 401 JV in th short to medium term.. £25 mn CT III cost plus a license / royalty or other incentive which should hopefully be announced this year but we are expected to believe its very close or progressing rapidally. I reckon £75mn to £100mn total package is not over egging it which is worth at 60% interest to VAL so including current SP, I’d say in the 8p -12p range, but with updates on 201 and the other compounds maybe 15p but who knows!!!! Very difficult to gauge but upon the first commercialisation with 401, the stock could get a complete overhaul and re-rating. All IMHO, NAG

Yes, but as was expected nothing new to report. Everything progresding nicely though so SP should mist probabaly be unchanged.

Well advanced to me means they have an inprincipal agreement and ironing out the finer details. This is not a simple home mortgage but a onocolgical compound!

Agree The Cream People losing focus on what has been achieved. A US patent for example is unique for a microcap bio. Commercialisation just around the corner. A new chapter for VAL.

If it hits the 52 week high, vhances are that it will continue. The next news is value enhancing. The past news has been developmental, hence teh rise and ghen pullback. GLA

Of course they have been talking to pharmas, but there is distinct difference between teaming up for RnD and commerciaising an oncological product which is their first time. Unfortunately we don’t know the details of the 401 talks nor will we until completed nor the timing, so everyone will have to be patient and stop fretting.

I think this answers your question Tozerk: “commercial discussions to take their lead drug VAL 401 into a Phase III trial are progressing rapidly. He says by nature they're detailed and complex but he hopes they'll be completed shortly and he's looking to undertake the trial early next year.“

Yes, LTH’s unfortunately mis-timed their entry point, but perhaps not by their own making. The company is in a very different place now with to date 2 pre-CT compounds, a prostate cancer compound showing excellent progress and 401 to be commercialised and the first time in VALs history that they will have satisfied their business model from development ——-> trade sale. So yes they are in a very exciting place to say their naive years back in 2010 /11 when they learning to walk.

Using Apple as an example: Early 80’s started out with the slow cumbersome computers with constant fund raising and nearly went bankrupt = VAL’s testing kits Then the dawn of Apple came with the iPhone, iPad etc starting an unprecedented global scale of growth becoming a trillion mkt cap company. VALs dawn is here now, reinvented itself with 101, 201, 301 and 401. Flip, sometimes a companires fortunes and journey is not all smooth running, with a nice steady level of growth. Sometimes you have to reinvent yourself to survive and prosper! Blind faith? No, but faith in there oncological compounds which is why I bought on Friday and will keep buying this week on the SP pullback.

Yes I’ m after the mansion (401)! They have hired bio negotiators to handle commercial deals now: “announces that it has established US operations in Cambridge, Boston, Massachusetts and has strengthened its US advisory team following the appointment of industry specific advisors in the US.”

Whats your point Flip? I am invested for 401 JV and 201 in 2019 so makes fxxx all difference to me, LOL. GLA

Well firstly not quite in the same league as the oncology compounds and whey before I invested back in 2010, but they were never going to make big bucks. A deal was done with Biovei for OTC distribution, but that was ValiMedix

What was your question Flip?

No, not at all. Hold, sell or buy more but stop the broken record Tozerk. What are you Tozerk a buyer, holder or seller? Bought 100k Friday and in for more this week - I’m a strong buyer.